Purpose Exudative age-related macular degeneration (ARMD) is one of the debilitating ocular complications, which results in permanent blindness. Elevated homocysteine (Hcys) levels have been associated in the development of several vascular diseases. Vascular and oxidative stress theories have been implicated for the development of choroidal neovascularization in exudative ARMD. The aim of the present study was to investigate the possible role of plasma Hcys and thiol content (tSH) as a risk factor for the development of exudative ARMD. Method A total of 16 patients with exudative ARMD and 20 age-matched controls were recruited for the study. Plasma Hcys levels were analysed using Reverse Phase High Performance Liquid Chromatography. Plasma glutathione (GSH) content was determined using o-phthalaldehyde (OPA) derivatization and subsequent detection by fluorimeter. Plasma tSH levels were determined by using thiol-specific reagent dithionitrobenzoic acid (DTNB) spectrophotometrically. Results Plasma Hcys levels in exudative ARMD were elevated three-fold (1875.0 lM) when compared to healthy controls (6.771.8 lM). There was a two-fold decrease in the GSH and tSH in exudative ARMD when compared with controls. Negative correlation was observed between diminished tSH and Hcys levels (r ¼ À0.4837, P ¼ 0.05). Similarly plasma Hcys levels negatively correlated with GSH content (r ¼ À0.6620, Po0.05). Conclusion Results from our present study revealed that there is an elevated Hcys level and diminished thiol pool content in exudative ARMD that are significant.
Introduction
Age-related macular degeneration (ARMD) is one of the leading causes of blindness among the elderly in the world. 1 It is a complex multifactorial disease that affects the central region of the retina. There are two forms of ARMD, nonexudative (dry) and exudative (wet). Wet ARMD is characterized by the presence of choroidal neovascularization with disciform scar representing the end stage. 2 Several risk factors such as cigarette smoking, sunlight exposure, obesity, hypertension, and hypercholesterolaemia have been associated with the development of ARMD. 3 In exudative ARMD the formation of choroidal neovascular membrane (CNV) has been attributed to the elaboration of growth factors, cytokines, and proteases. 4 Thus different biochemical pathways leading to geographic atrophy and/ or choroidal new vessels may operate simultaneously. Many unanswered questions regarding AMD pathogenesis especially on role of oxidative stress remains. 5 Epidemiological studies of diet, environmental, and behavioural risk factors suggest that oxidative stress is a contributing factor of AMD. 6, 7 Homocysteine, an intermediary amino acid formed during the conversion of methionine to cysteine, is rapidly auto-oxidized in plasma, forming homocystine (Hcys), mixed disulfides, and Hcys thiolactone. Potent reactive oxygen species, including superoxide anion and hydrogen peroxide, are produced during the auto-oxidation of Hcys. 8, 9 Elevated Hcys levels has been shown to induce vascular injury, aiding in atherothrombogenesis and this has been considered as an independent risk factor for the development of vascular diseases. 5, 6 Several lines of evidence suggest that occlusion of choroidal vessels lead to the development of choroidal neovascularization which is a major determinant in promoting visual loss in patients with exudative ARMD. 7 Axer-Siegel et al 10 demonstrated an association of elevated plasma level of Hcys and exudative neovascular ARMD in a cohort of 59 patients. In our study, we investigated plasma Hcys, glutathione (GSH) and thiol content (tSH) as the possible risk factor for the development of wet ARMD.
Materials and methods

Patients and control subjects
A total of 16 patients with wet ARMD (age group of 51-82 years with the mean age of 66 years (11 M and 5 F) and 20 age-matched healthy controls in the age group of 55-75 years with the mean age of 62 years (8 M and 12 F) were recruited for the study. Demographic details are presented in Table 1 . Patients recruited for the study either had CNV or disciform scar. The grading of the CNV was based on the age-related eye disease study group (AREDS) recommendation. Subjects with history of diabetes mellitus, renal disease, hypertension, cardiovascular disease, smokers, alcoholics, and subjects who are on antioxidant supplements were excluded from the study. The physician and ophthalmologist ruled out any systemic/ophthalmic diseases from the control subjects before recruitment after a detailed check up. Informed consent was obtained from all the participants in the study. The authors' institutional research and ethical committee approved the study. All procedures pertaining to human subjects strictly adhered to tenets of Helsinki declaration.
Blood samples were collected after ensuring overnight fasting and plasma was separated immediately. All the assays were performed on the same day.
Chemicals
All the fine chemicals used in the study were procured from Sigma chemical company (MO, USA) unless specified. HPLC solvents were purchased from E-Merck Chemicals, Mumbai, India.
Determination of plasma homocysteine
Plasma Hcys levels were determined using HPLC as described by Jayatilleke and Shaw with slight modifications. 11 In brief, equal volume of 10% TCA (W/V) was added to 0.5 ml plasma and vortexed thoroughly followed by centrifugation at 5000 rpm for 15 min at 41C. The supernatant was filtered through 0.22 m syringe filter. In all, 10 ml aliquot of the filtered supernatant was diluted to 1.0 ml with degassed Milli Q water. From this 50 ml was injected into C18 column (Licrosphere, Merck, Darmstadt, Germany). Isocratic elution was performed using 0.0025 M Na 2 HPO 4 buffer, pH 3.5 containing 50 mM tetrabutylammonium dihydrogen phosphate and 13% methanol, at the flow rate of 0.3 ml/min. Elution was monitored at 190 nm. The analysis was carried out using Agilent 1100 series HPLC system equipped with binary solvent pump, column thermostat, and variable wavelength detector. Prior to analysis of Hcys in clinical samples, the system was calibrated with authentic Hcys standards in the range of 3.0-50.0 mM. Intra-assay variation for Hcys was found to be 1.35 mM.
Determination of plasma GSH
Plasma GSH was determined by following the method of Miuo-Lin Hu with slight modifications. 12 Briefly 0.5 ml of plasma was added to 0.5 ml of ice cold 10% TCA, vortexed and kept in ice for 10 min followed by centrifugation to remove the protein pellet. To 0.2 ml aliquot of the supernatant added 1.7 ml of 0.1 M sodium phosphate buffer containing 5 mM EDTA, pH 8.0 and 0.1 ml of o-phthalaldehyde (1 mg/ml in methanol). The 
Determination of plasma total tSH
Plasma total tSH was determined by the method of Miuo-Lin Hu with slight modifications. 12 Briefly 50 ml of plasma was mixed with 0.25 M Tris EDTA buffer, pH 8.2 and the absorbance was measured at 412 nm. To this 20 ml of 10 mM dithionitrobenzene (DTNB) was added and kept at room temperature for 15 min. The absorbance was again measured at 412 nm against DTNB blank. The total tSH was calculated using the molar absorption coefficient (e) 13 600 cm À1 M À1 . Intra-assay variation was found to be 0.07 mM.
Statistical analysis
All values were expressed as mean7SD. Statistical tests such as Student's 't' and Pearson w 2 test were used to compare means and proportions, respectively. Pearson's correlation test was employed to assess the relationship between Hcys levels with GSH, and tSH. Statistical significance was defined as Po0.05.
Results
The levels of plasma Hcys, GSH, and tSH determined in patients and control subjects are given in Table 2 . There was a statistically significant difference in plasma Hcys between the cases and controls. (Pp0.05). Plasma Hcys levels were found to be three-fold higher in patients with wet ARMD compared to control subjects (95% CI for mean difference À14.262À9.12), while the plasma GSH levels and the tSH levels were decreased significantly by nearly 50% (Pp0.05, 95% CI for mean difference: GSH levels 1.60723.31 and for tSH levels 0.1120.27). The gender differences in levels between the cases and controls were not statistically significant (Pearson's w 2 ¼ À2.953, P ¼ 0.87) A significant correlation was observed between levels of Hcys and GSH content in patients with wet ARMD (r ¼ À0.6620, Po0.05) (Figure 1) . Similarly a significant negative correlation was observed between tSH content and Hcys levels (r ¼ À0.4837, P ¼ 0.05) in patients with wet ARMD (Figure 2 ).
Discussion
Choroidal neovascularization has been attributed to be the major cause of visual loss in patients with wet ARMD. 13 Pathogenesis of choroidal neovascularization in ARMD involves a complex interplay of environmental, biochemical changes, and genetic predisposition. Hcys has been shown to undergo autoxidation in the presence of transition metal ions like iron which culminates in the generation of hydroxyl radical (OH K ). OH K thus generated initiates the oxidation of LDL and this has been shown to induce the vascular dysfunction. [20] [21] [22] In our present study, we have detected elevated levels of Hcys and diminished tSH in patients with wet ARMD. A recent study on the assessment of the relationship between plasma Hcys levels and exudative neovascular AMD has suggested that there is an association between an elevated plasma level of Hcys and exudative neovascular ARMD but not dry ARMD. 10 An earlier study by Heuberger et al 23 has shown that ARMD does not appear to be associated with Hcys or its dietary determinants and has suggested further investigations in subgroups with low folate status. 23 Thus, further studies have to be performed to assess the role of nutritional status in correlation between hyperhomocystenaemia and wet ARMD.
Under normal circumstances, spontaneous oxidation of Hcys is prevented by GSH. However, during pathological conditions and in ageing process GSH and thiol pool has been reported to decrease, which aids in Hcys oxidation that results in oxidative insult to the tissue. 24, 25 Recently, Sameic et al 26 has reported that GSH levels were diminished in plasma of patients with ARMD and ageing. In one of the study reports, while estimating the enzymatic and nonenzymatic components of the antioxidant system it was shown that the average concentrations of vitamin A and C were low and vitamin E and GSH were significantly higher in patients with ARMD than in the control group, with the activity of almost all the antioxidant enzymes being high, showing that there is an adaptive increase in the antioxidant barrier of mostly the enzymatic components. 27 The multicentre, double-blind cross-sectional study reported by Everklioglu et al has shown that late ARMD patients had significantly lower antioxidant enzyme levels and higher MDA levels when compared with early ARMD patients, which may reflect the levels of the various antioxidants including GSH. 16 Therefore, grouping of the patients based on the clinical picture seems to be crucial before arriving at conclusions.
Based on the results from our present study and supportive theories by other investigators, it is quite possible that hyperhomocysteinaemia (Hhcys) and prevailing oxidative stress could synergistically play an important role in the pathogenesis of wet ARMD by inducing vascular dysfunction.
